Skip to main content
. 2023 May 24;23:347. doi: 10.1186/s12879-023-08288-8

Table 1.

Mean and standard deviation of demographic characteristics, Viral loads and CD4 + T cell counts at baseline and upon virologic failure according to the HIV resistance profile

N Age (years)a Males n(%) Females n(%) Viral Load at virologic failurea CD4 at virologic failurea Baseline Viral Loada Baseline CD4a
Wild Type HIV 65 35.7(10.27) 42(73.68) 15(26.32) 4.91(5.263) 438(332.5) 5.66(6.112) 391(359)
TL + D RAMS 2 34.0(4.243) 2(100.00) 0(0.00) 5.35(5.413) 53.5(30.41) 6.12(6.112) 45.5(55.86)
TL RAMS 6 37.2(15.79) 3(50.00) 3(50.00) 5.44(5.662) 175(172.6) 5.87(6.029) 161(170.8)
Major INRAMS 7 37.9(14.35) 5(71.43) 2(28.57) 5.01(5.145) 238(218.4) 5.73(5.935) 184(211.2)
Minor INRAMS 18 33.6(10.58) 12(75.00) 4(25.00 5.17(5.411) 281(237.9) 5.77(5.84) 179(178.85)
NRTI RAMS 15 35.1(11.43) 10(71.43) 4(28.57) 5.50(5.853) 221(188.7) 5.90(6.015) 207(193.8)
NNRTI RAMS 16 35.5(12.29) 9(69.23) 4(30.77) 5.17(5.595) 356(200.6) 5.35(5.686) 304(149.8)
PI RAMS 6 38.8(10.43) 4(80.00) 1(20.00) 4.93(5.077) 216(176.8) 5.28(5.286) 212(158.2)
Total 113b 36.1(10.77) 73(73.00) 27(27.00) 5.13(5.55) 365.9(294.1) 5.67(6.034) 323.2(305.6)

The total n of 113 is less than the sum of the n’s in the categories as there were many cases that had multiple categories of RAMs

TL Tenofovir/lamivudine, D Dolutegravir, RAM Resistance-associated mutations, INRAM Integrase resistance-associated mutations, NRTI Nucleoside reverse transcriptase inhibitor, NNRTI Non-nucleoside reverse transcriptase inhibitor, PI Protease inhibitors

aMean(std. dev.)

bone sample failed in the RT and protease PCR amplification